Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.

Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.

Item
http://www.wikidata.org/entity/Q34647625
Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primatesHSV-2: in pursuit of a vaccineA novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in mice.Pan-HSV-2 IgG antibody in vaccinated mice and guinea pigs correlates with protection against herpes simplex virus 2.A mucosal vaccination approach for herpes simplex virus type 2.Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alphaAttenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in miceSingle-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection.Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity.New concepts in herpes simplex virus vaccine development: notes from the battlefield.Intramuscular immunization with a vesicular stomatitis virus recombinant expressing the influenza hemagglutinin provides post-exposure protection against lethal influenza challenge.A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines?Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
P2860

Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.

Item
http://www.wikidata.org/entity/Q34647625
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Recombinant vesicular stomatit ...... g models of vaginal challenge.
@ast
Recombinant vesicular stomatit ...... g models of vaginal challenge.
@en
Recombinant vesicular stomatit ...... g models of vaginal challenge.
@nl
type
label
Recombinant vesicular stomatit ...... g models of vaginal challenge.
@ast
Recombinant vesicular stomatit ...... g models of vaginal challenge.
@en
Recombinant vesicular stomatit ...... g models of vaginal challenge.
@nl
prefLabel
Recombinant vesicular stomatit ...... g models of vaginal challenge.
@ast
Recombinant vesicular stomatit ...... g models of vaginal challenge.
@en
Recombinant vesicular stomatit ...... g models of vaginal challenge.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Recombinant vesicular stomatit ...... g models of vaginal challenge.
@en
P2093
P2860
P304
P31
P356
10.1128/JVI.80.9.4447-4457.2006
P407
P433
P478
P577
P698
P921
P932